Gyre Therapeutics, Inc. GYRE Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s operating income?
- Gyre Therapeutics, Inc. (GYRE) reported operating income of -$9.36M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s operating income changed year-over-year?
- Gyre Therapeutics, Inc.'s operating income decreased by 511.6% year-over-year, from $2.27M to -$9.36M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s operating income?
- Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s operating income has grown at a -49.3% compound annual growth rate (CAGR), from -$87.89M to $11.49M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.